Tag: FORT

National Biopharmaceutical Company FORT LLC – Russian national full-cycle biopharmaceutical company. Company directions are: researching, developing, manufacturing and marketing of innovative biological medicines.
In 2014, FORT successfully completed a project for the construction of its own complete cycle of research and production complex compliant to the international Good Manufacturing Practice. The factory is located in the Ryazan region on the territory of 16.5 hectares, the total area of ​​outstanding buildings is 39.8 thousand square meters.
The company meets all international license requirements for work with micro-organisms (even the dangerous ones) causing the infection. Plant for vaccine production, laboratory and warehouse and all modern infrastructural facilities to ensure full operation of the plant were launched .
The production capacity of the first stage is 40 million doses of seasonal influenza vaccines, or, if necessary, 120 million doses of pandemic influenza vaccines; 20 million doses of other anti-viral vaccines; 100 million doses of recombinant pharmaceutical proteins.

Marathon Pharma buys a controlling stake in the Fort plant

fort
Marathon Pharma Group signed an agreement to acquire a controlling stake in Fort LLC, a biopharmaceutical company that is a part of Nacimbio of Rostec Corporation.

Quadrivalent influenza vaccine will be available in Russia by 2019

Russian manufacturers of pharmaceuticals are ready to present a new quadrivalent influenza vaccine protecting against four different flu strains before the start of epidemic season in 2019. “It is ...

Students of the Ryazan Medical University will be able to undertake an internship at the FORT produc...

FORT - Student Tour
On 18-19th of January 2017, the fourth year students of the Faculty of Pharmacy and the leading teachers of the Department of pharmaceutical technology in the framework of a cooperation agreement with...